Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johan Gobom

Showing results (131-140 of 139) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 139 results.
Molecular Neurodegeneration|March 29, 2022
Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer's diseasePieter Jelle Visser, Lianne M Reus, Johan Gobom, et al.
Molecular Neurodegeneration|May 13, 2022
Correction: Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer's diseasePieter Jelle Visser, Lianne M Reus, Johan Gobom, et al.
Nature Medicine|January 17, 2025
Somatic CAG repeat expansion in blood associates with biomarkers of neurodegeneration in Huntington's disease decades before clinical motor diagnosisRachael I Scahill, Mena Farag, Michael J Murphy, et al.
Acta Neuropathologica|December 30, 2023
Optimal blood tau species for the detection of Alzheimer's disease neuropathology: an immunoprecipitation mass spectrometry and autopsy studyLaia Montoliu-Gaya, Michael L Alosco, Eukyung Yhang, et al.
Alzheimer'S Research & Therapy|August 31, 2022
Differential impairment of cerebrospinal fluid synaptic biomarkers in the genetic forms of frontotemporal dementiaAitana Sogorb-Esteve, Johanna Nilsson, Imogen J Swift, et al.
Medrxiv : the Preprint Server for Health Sciences|September 4, 2024
The Alzheimer's Association Global Biomarker Standardization Consortium (GBSC) plasma phospho-tau Round Robin studyNicholas J Ashton, Ashvini Keshavan, Wagner S Brum, et al.
Science Translational Medicine|February 5, 2025
Proteomic analysis reveals distinct cerebrospinal fluid signatures across genetic frontotemporal dementia subtypesAitana Sogorb-Esteve, Sophia Weiner, Joel Simrén, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 5, 2025
The Alzheimer's Association Global Biomarker Standardization Consortium (GBSC) plasma phospho-tau Round Robin studyNicholas J Ashton, Ashvini Keshavan, Wagner S Brum, et al.
Acta Neuropathologica|September 6, 2022
Genome-wide meta-analysis for Alzheimer's disease cerebrospinal fluid biomarkersIris E Jansen, Sven J van der Lee, Duber Gomez-Fonseca, et al.
Pageof 14

Showing results (131-140 of 139) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 139 results.
Molecular Neurodegeneration|March 29, 2022
Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer's diseasePieter Jelle Visser, Lianne M Reus, Johan Gobom, et al.
Molecular Neurodegeneration|May 13, 2022
Correction: Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer's diseasePieter Jelle Visser, Lianne M Reus, Johan Gobom, et al.
Nature Medicine|January 17, 2025
Somatic CAG repeat expansion in blood associates with biomarkers of neurodegeneration in Huntington's disease decades before clinical motor diagnosisRachael I Scahill, Mena Farag, Michael J Murphy, et al.
Acta Neuropathologica|December 30, 2023
Optimal blood tau species for the detection of Alzheimer's disease neuropathology: an immunoprecipitation mass spectrometry and autopsy studyLaia Montoliu-Gaya, Michael L Alosco, Eukyung Yhang, et al.
Alzheimer'S Research & Therapy|August 31, 2022
Differential impairment of cerebrospinal fluid synaptic biomarkers in the genetic forms of frontotemporal dementiaAitana Sogorb-Esteve, Johanna Nilsson, Imogen J Swift, et al.
Medrxiv : the Preprint Server for Health Sciences|September 4, 2024
The Alzheimer's Association Global Biomarker Standardization Consortium (GBSC) plasma phospho-tau Round Robin studyNicholas J Ashton, Ashvini Keshavan, Wagner S Brum, et al.
Science Translational Medicine|February 5, 2025
Proteomic analysis reveals distinct cerebrospinal fluid signatures across genetic frontotemporal dementia subtypesAitana Sogorb-Esteve, Sophia Weiner, Joel Simrén, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 5, 2025
The Alzheimer's Association Global Biomarker Standardization Consortium (GBSC) plasma phospho-tau Round Robin studyNicholas J Ashton, Ashvini Keshavan, Wagner S Brum, et al.
Acta Neuropathologica|September 6, 2022
Genome-wide meta-analysis for Alzheimer's disease cerebrospinal fluid biomarkersIris E Jansen, Sven J van der Lee, Duber Gomez-Fonseca, et al.
Pageof 14